Clinical indicators of gestational diabetes treated with insulin detemir
XU Jingjie1, WANG Lihua1, ZHANG Qiang1, CHEN Zhuo2
1. Inner Mongolia Corps Hospital,Chinese People’s Armed Police Force,Hohhot 010010,China; 2.Department of Medical Support, the Third Medical Center of PLA General Hospital, Beijing 100039, China
Abstract：Objective To observe the clinical efficacy and related indicators of insulin detemir in the treatment of gestational diabetes mellitus.Methods The clinical data of 88 patients diagnosed with GDM between June 2016 and June 2017 was selected. According to options of treatment,these patients were divided into two groups, with 44 cases in each. The control group was treated with subcutaneous injection of Humulin N, while the observation group was subcutaneously injected with insulin detemir. The clinically relevant indicators were compared between the two groups.Results After 2 weeks of treatment, the blood glucose index and pregnancy outcome of the observation group were significantly better than those of the control group. The difference was statistically significant(P<0.05).Conclusion For patients with gestational diabetes mellitus, insulin detemir is safe and effective, which can help control their blood glucose levels, improve the maternal and infant outcomes and induce lower incidence of hypoglycemia.
Hod M,Kapur A,Sacks D A,et al.The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care[J].Int J Gynaecol Obstet,2015,131:S173.
[5]
Koivusalo S B,Rönö K, Stachlempinen B, et al. Response to Comment on Koivusalo et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial[J]. Diabetes Care,2016,39:24-30.
2019, Vol. 30 
